Non-interventional Study to Investigate Efficacy and Safety of Trabectedin (Yondelis) in Patients With Advanced Soft Tissue Sarcoma

Trial Profile

Non-interventional Study to Investigate Efficacy and Safety of Trabectedin (Yondelis) in Patients With Advanced Soft Tissue Sarcoma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Trabectedin (Primary)
  • Indications Soft tissue sarcoma
  • Focus Therapeutic Use
  • Acronyms YonSar
  • Sponsors PharmaMar
  • Most Recent Events

    • 27 Sep 2016 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
    • 27 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jan 2018.
    • 14 Sep 2015 According to a PharmaMar media release, data from this study will be presented at the 18th ECCO - 40th ESMO European Cancer Congress (ECC 2015).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top